In Section A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra members will be enrolled on the determined monotherapy dosign program. In Phase B, participants will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In Segment C, https://abbv-744clinicaltrialphas24802.blogpixi.com/32373895/the-2-minute-rule-for-is-abbv-744-effective-for-hematologic-cancers